Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pavli

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Inflammatory Bowel Diseases|January 19, 2012
Foot drop developing during infliximab therapy for inflammatory bowel diseaseK Subramaniam, A Hughes, P Pavli
Gastrointestinal Endoscopy|January 12, 2001
Small bowel obstruction caused by colonoscopyS A Malki, M L Bassett, P Pavli
Alimentary Pharmacology & Therapeutics|January 16, 2007
Perioperative acute upper gastrointestinal haemorrhage in older patients with hip fracture: incidence, risk factors and preventionL Fisher, A Fisher, P Pavli, et al.
Internal Medicine Journal|September 5, 2015
Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitorsK Subramaniam, K Tymms, B Shadbolt, et al.
Journal of Gastroenterology and Hepatology|February 24, 1999
Images of interest. Gastrointestinal: adenocarcinoma of the lower oesophagusG Pawar, P Pavli, I C Roberts-Thomson
Inflammatory Bowel Diseases|October 12, 2011
Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolateK Subramaniam, S Chitturi, M Brown, et al.
Inflammatory Bowel Diseases|October 12, 2011
Should patients be screened for hereditary cancer syndromes before starting anti-TNF-α therapy?K Subramaniam, K Tucker, P Craft, et al.
Current Drug Safety|August 10, 2012
Glatiramer acetate induced hepatotoxicityK Subramaniam, P Pavli, H Llewellyn, et al.
Internal Medicine Journal|May 13, 2016
Safe and effective: anti-tumour necrosis factor therapy use in pregnant patients with Crohn disease and ulcerative colitisC J Kiely, K Subramaniam, J Platten, et al.
The American Journal of Gastroenterology|July 1, 1997
Toxocara canis infection and granulomatous hepatitisS P Kaushik, M Hurwitz, C McDonald, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Inflammatory Bowel Diseases|January 19, 2012
Foot drop developing during infliximab therapy for inflammatory bowel diseaseK Subramaniam, A Hughes, P Pavli
Gastrointestinal Endoscopy|January 12, 2001
Small bowel obstruction caused by colonoscopyS A Malki, M L Bassett, P Pavli
Alimentary Pharmacology & Therapeutics|January 16, 2007
Perioperative acute upper gastrointestinal haemorrhage in older patients with hip fracture: incidence, risk factors and preventionL Fisher, A Fisher, P Pavli, et al.
Internal Medicine Journal|September 5, 2015
Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitorsK Subramaniam, K Tymms, B Shadbolt, et al.
Journal of Gastroenterology and Hepatology|February 24, 1999
Images of interest. Gastrointestinal: adenocarcinoma of the lower oesophagusG Pawar, P Pavli, I C Roberts-Thomson
Inflammatory Bowel Diseases|October 12, 2011
Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolateK Subramaniam, S Chitturi, M Brown, et al.
Inflammatory Bowel Diseases|October 12, 2011
Should patients be screened for hereditary cancer syndromes before starting anti-TNF-α therapy?K Subramaniam, K Tucker, P Craft, et al.
Current Drug Safety|August 10, 2012
Glatiramer acetate induced hepatotoxicityK Subramaniam, P Pavli, H Llewellyn, et al.
Internal Medicine Journal|May 13, 2016
Safe and effective: anti-tumour necrosis factor therapy use in pregnant patients with Crohn disease and ulcerative colitisC J Kiely, K Subramaniam, J Platten, et al.
The American Journal of Gastroenterology|July 1, 1997
Toxocara canis infection and granulomatous hepatitisS P Kaushik, M Hurwitz, C McDonald, et al.
Pageof 5